Overview
INFORMATION TO COURSE PARTICIPANTS: PLEASE DOWNLOAD COURSE MATERIAL FROM THE DIA WEBSITE
Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing
This course is designed to provide a firm grounding in key aspects of Global and mainly European Clinical Pre- and Post-Marketing Safety regulatory requirements. This five-day training course now also includes highlights and updates on the pharmacovigilance legislation and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.
What participants from previous course say:
"Thank you for a great and comprehensive course. It was great to hear the perspectives of the different speakers as well as to meet a number of people working within this sector"
"A well organised course in an excellent location. The course director should be commended!"
"A very interesting course with lots of takeaway reading to do. The meeting was very well organised and the day schedule was kept to plan"
Program Committee
-
Gaby L. Danan, MD, PhD Pharmacovigilance Expert
GLD, France -
Phil Tregunno Deputy Director - Patient Safety Monitoring
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Have an account?